Asia Pacific Mid-Size Pharmaceutical Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Mid-Size Pharmaceutical Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Mid-Size Pharmaceutical Market Regional Analysis

6.2 Asia Pacific Mid-Size Pharmaceutical Market Revenue 2020-2028 (US$ Million)

6.3 Asia Pacific Mid-Size Pharmaceutical Market Forecast Analysis

7. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Type

7.1 Prescription

7.1.1 Overview
7.1.2 Prescription: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Over-the-Counter

7.2.1 Overview
7.2.2 Over-the-Counter: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Drug Development Type

8.1 In-House

8.1.1 Overview
8.1.2 In-House: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Outsource

8.2.1 Overview
8.2.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Formulation

9.1 Tablets and Capsules

9.1.1 Overview
9.1.2 Tablets and Capsules: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Injectables

9.2.1 Overview
9.2.2 Injectables: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Sprays

9.3.1 Overview
9.3.2 Sprays: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Other Formulations

9.4.1 Overview
9.4.2 Other Formulations: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Therapy Class

10.1 Cardiovascular Diseases

10.1.1 Overview
10.1.2 Cardiovascular Diseases: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Pain Management

10.2.1 Overview
10.2.2 Pain Management: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Diabetes

10.3.1 Overview
10.3.2 Diabetes: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 Cancer

10.4.1 Overview
10.4.2 Cancer: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.5 Other Conditions

10.5.1 Overview
10.5.2 Other Conditions : Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Asia Pacific Mid-Size Pharmaceutical Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
11.2.1.1.2 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
11.2.1.1.3 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation
11.2.1.1.4 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Therapy Class

11.2.1.2 India: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
11.2.1.2.2 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
11.2.1.2.3 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation
11.2.1.2.4 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Therapy Class

11.2.1.3 Japan: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
11.2.1.3.2 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
11.2.1.3.3 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation
11.2.1.3.4 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Therapy Class

11.2.1.4 Australia: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
11.2.1.4.2 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
11.2.1.4.3 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation
11.2.1.4.4 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Therapy Class

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Therapy Class

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Alexion Pharmaceuticals, Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Daiichi Sankyo Company Limited

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Eisai Co., Ltd.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Endo Pharmaceuticals Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Mallinckrodt

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Regeneron Pharmaceuticals, Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sun Pharmaceutical Industries Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Mid-Size Pharmaceutical Market

Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)